JPMorgan Chase & Co’s Marinus Pharmaceuticals, Inc MRNS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-487,584
Closed -$261K 6707
2024
Q4
$261K Buy
487,584
+354,393
+266% +$190K ﹤0.01% 4432
2024
Q3
$234K Buy
133,191
+126,752
+1,969% +$223K ﹤0.01% 4402
2024
Q2
$7.53K Sell
6,439
-27,195
-81% -$31.8K ﹤0.01% 5304
2024
Q1
$304K Sell
33,634
-10,399
-24% -$94K ﹤0.01% 4227
2023
Q4
$479K Buy
44,033
+82
+0.2% +$891 ﹤0.01% 3937
2023
Q3
$354K Buy
43,951
+3,667
+9% +$29.5K ﹤0.01% 3908
2023
Q2
$437K Buy
40,284
+39,536
+5,286% +$429K ﹤0.01% 3833
2023
Q1
$5K Buy
748
+128
+21% +$856 ﹤0.01% 5400
2022
Q4
$2K Sell
620
-1,940
-76% -$6.26K ﹤0.01% 5406
2022
Q3
$17K Buy
2,560
+490
+24% +$3.25K ﹤0.01% 4970
2022
Q2
$10K Sell
2,070
-290,790
-99% -$1.4M ﹤0.01% 5186
2022
Q1
$2.74M Sell
292,860
-5,261
-2% -$49.2K ﹤0.01% 2968
2021
Q4
$3.54M Sell
298,121
-13,804
-4% -$164K ﹤0.01% 2809
2021
Q3
$3.55M Buy
311,925
+180,939
+138% +$2.06M ﹤0.01% 2812
2021
Q2
$2.35M Sell
130,986
-59,107
-31% -$1.06M ﹤0.01% 3127
2021
Q1
$2.94M Buy
190,093
+27,834
+17% +$431K ﹤0.01% 2998
2020
Q4
$1.98M Sell
162,259
-35,126
-18% -$428K ﹤0.01% 2973
2020
Q3
$2.29M Sell
197,385
-106,277
-35% -$1.24M ﹤0.01% 2678
2020
Q2
$3.09M Sell
303,662
-66,435
-18% -$675K ﹤0.01% 2455
2020
Q1
$3.01M Buy
370,097
+245,717
+198% +$2M ﹤0.01% 2340
2019
Q4
$1.08M Buy
124,380
+120,267
+2,924% +$1.04M ﹤0.01% 3028
2019
Q3
$25K Buy
4,113
+667
+19% +$4.05K ﹤0.01% 4433
2019
Q2
$54K Buy
3,446
+580
+20% +$9.09K ﹤0.01% 4223
2019
Q1
$48K Sell
2,866
-6,549
-70% -$110K ﹤0.01% 4258
2018
Q4
$108K Sell
9,415
-19,358
-67% -$222K ﹤0.01% 4019
2018
Q3
$1.15M Buy
28,773
+2,222
+8% +$88.9K ﹤0.01% 3085
2018
Q2
$751K Buy
26,551
+2,122
+9% +$60K ﹤0.01% 3272
2018
Q1
$373K Buy
+24,429
New +$373K ﹤0.01% 3492
2016
Q2
Sell
-2,375
Closed -$51K 4383
2016
Q1
$51K Buy
+2,375
New +$51K ﹤0.01% 3416